Following contentious protests on college campuses across the country in 2024, President Donald Trump announced the formation ...

SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) ("SELLAS'' or the "Company”), a late-stage clinical biopharmaceutical company focused on the development of novel therapies for a broad range of cancer ...

Using an algorithm they call the Krakencoder, researchers at Weill Cornell Medicine are a step closer to unraveling how the ...